JP Morgan Sweeps the Board on Friday

JP Morgan dominated Friday's analyst tape. The bank raised target prices on at least ten names in a single session, while trimming three others.

The biggest lift in absolute terms went to COST. JP Morgan's Christopher Horvers lifted his target on Costco from $1,015 to $1,150, keeping a Buy rating. The warehouse retailer carries broad analyst support, with 26 Buy ratings among covering analysts.

CDW got a sharp jump too. Joseph Cardoso raised his target from $170 to $195 on the IT solutions distributor, though seven of the ten covering analysts still hold a Sell. That's an unusual split for a stock with a Buy from the same desk.

Medical device names saw upgrades as well. Robbie Marcus at JP Morgan raised his target on EW from $105 to $120, maintaining Buy. Edwards Lifesciences has 24 Sell ratings in the consensus, making the Buy an outlier call. Marcus also nudged PODD higher, lifting Insulet's target from $152 to $170 on a Hold.

On the downside, FICO took the sharpest cut. JP Morgan's Alexander Hess slashed the Fair Isaac target from $900 to $800, holding a Neutral stance. The scoring company sits almost evenly split between buyers and sellers in analyst consensus.

QCOM also saw a trim. Samik Chatterjee cut the Qualcomm target from $215 to $200 on a Hold, as the chip sector faces mixed signals heading into year-end.

IFF drew attention from two separate desks. Both JP Morgan and Citigroup raised targets on International Flavors and Fragrances on the same morning, suggesting renewed confidence in the specialty chemicals group.